ARCOSA INC (ACA) Fundamental Analysis & Valuation

NYSE:ACA • US0396531008

Current stock price

119.44 USD
-0.75 (-0.62%)
At close:
119.44 USD
0 (0%)
After Hours:

This ACA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ACA Profitability Analysis

1.1 Basic Checks

  • ACA had positive earnings in the past year.
  • In the past year ACA had a positive cash flow from operations.
  • In the past 5 years ACA has always been profitable.
  • Each year in the past 5 years ACA had a positive operating cash flow.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • With a Return On Assets value of 4.17%, ACA perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • ACA's Return On Equity of 7.88% is in line compared to the rest of the industry. ACA outperforms 49.09% of its industry peers.
  • With a Return On Invested Capital value of 5.80%, ACA perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 13.91%.
  • The 3 year average ROIC (4.62%) for ACA is below the current ROIC(5.80%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.17%
ROE 7.88%
ROIC 5.8%
ROA(3y)3.51%
ROA(5y)4%
ROE(3y)6.18%
ROE(5y)6.66%
ROIC(3y)4.62%
ROIC(5y)4.24%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • ACA's Profit Margin of 7.22% is fine compared to the rest of the industry. ACA outperforms 74.55% of its industry peers.
  • ACA's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 11.37%, ACA is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ACA has grown nicely.
  • Looking at the Gross Margin, with a value of 22.45%, ACA is in the better half of the industry, outperforming 70.91% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACA has grown nicely.
Industry RankSector Rank
OM 11.37%
PM (TTM) 7.22%
GM 22.45%
OM growth 3Y16.52%
OM growth 5Y6.57%
PM growth 3Y-12.89%
PM growth 5Y5.71%
GM growth 3Y5.99%
GM growth 5Y2.61%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ACA Health Analysis

2.1 Basic Checks

  • ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ACA has been increased compared to 1 year ago.
  • ACA has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ACA has been reduced compared to a year ago.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • ACA has an Altman-Z score of 2.71. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.71, ACA perfoms like the industry average, outperforming 43.64% of the companies in the same industry.
  • The Debt to FCF ratio of ACA is 8.68, which is on the high side as it means it would take ACA, 8.68 years of fcf income to pay off all of its debts.
  • ACA has a Debt to FCF ratio of 8.68. This is comparable to the rest of the industry: ACA outperforms 52.73% of its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that ACA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.57, ACA is in line with its industry, outperforming 56.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.68
Altman-Z 2.71
ROIC/WACC0.54
WACC10.77%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 2.20 indicates that ACA has no problem at all paying its short term obligations.
  • ACA has a better Current ratio (2.20) than 85.45% of its industry peers.
  • ACA has a Quick Ratio of 1.35. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ACA (1.35) is better than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.35
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ACA Growth Analysis

3.1 Past

  • ACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.50%, which is quite impressive.
  • The Earnings Per Share has been growing by 12.78% on average over the past years. This is quite good.
  • ACA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.20%.
  • Measured over the past years, ACA shows a quite strong growth in Revenue. The Revenue has been growing by 8.30% on average per year.
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
Revenue 1Y (TTM)12.2%
Revenue growth 3Y8.74%
Revenue growth 5Y8.3%
Sales Q2Q%7.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.28% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.33% on average over the next years.
EPS Next Y8.02%
EPS Next 2Y12.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.19%
Revenue Next 2Y5.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ACA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 26.72 indicates a quite expensive valuation of ACA.
  • Based on the Price/Earnings ratio, ACA is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of ACA to the average of the S&P500 Index (27.42), we can say ACA is valued inline with the index average.
  • A Price/Forward Earnings ratio of 24.74 indicates a rather expensive valuation of ACA.
  • Based on the Price/Forward Earnings ratio, ACA is valued a bit cheaper than the industry average as 78.18% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ACA to the average of the S&P500 Index (22.24), we can say ACA is valued inline with the index average.
Industry RankSector Rank
PE 26.72
Fwd PE 24.74
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ACA is valued a bit cheaper than 80.00% of the companies in the same industry.
  • ACA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACA is cheaper than 61.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 33.42
EV/EBITDA 13.02
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ACA has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ACA's earnings are expected to grow with 12.28% in the coming years.
PEG (NY)3.33
PEG (5Y)2.09
EPS Next 2Y12.28%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ACA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.17%, ACA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.14, ACA pays a better dividend. On top of this ACA pays more dividend than 81.82% of the companies listed in the same industry.
  • With a Dividend Yield of 0.17, ACA pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.17%

5.2 History

  • The dividend of ACA has a limited annual growth rate of 0.14%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)0.14%
Div Incr Years0
Div Non Decr Years6
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 4.81% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
  • The dividend of ACA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP4.81%
EPS Next 2Y12.28%
EPS Next 3YN/A
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ACA Fundamentals: All Metrics, Ratios and Statistics

ARCOSA INC

NYSE:ACA (4/24/2026, 8:19:56 PM)

After market: 119.44 0 (0%)

119.44

-0.75 (-0.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners94.28%
Inst Owner Change-0.01%
Ins Owners1.79%
Ins Owner Change8.11%
Market Cap5.86B
Revenue(TTM)2.88B
Net Income(TTM)208.10M
Analysts84
Price Target130.39 (9.17%)
Short Float %2.4%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0.17%
Yearly Dividend0.2
Dividend Growth(5Y)0.14%
DP4.81%
Div Incr Years0
Div Non Decr Years6
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.92%
Min EPS beat(2)15.61%
Max EPS beat(2)24.24%
EPS beat(4)4
Avg EPS beat(4)54.93%
Min EPS beat(4)15.61%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)28.84%
EPS beat(12)11
Avg EPS beat(12)33.04%
EPS beat(16)15
Avg EPS beat(16)36.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-3.72%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.48%
Revenue beat(12)6
Avg Revenue beat(12)0.12%
Revenue beat(16)10
Avg Revenue beat(16)1.69%
PT rev (1m)3.76%
PT rev (3m)3.26%
EPS NQ rev (1m)-0.62%
EPS NQ rev (3m)-19.37%
EPS NY rev (1m)-0.95%
EPS NY rev (3m)-1.36%
Revenue NQ rev (1m)0.86%
Revenue NQ rev (3m)-2.96%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 26.72
Fwd PE 24.74
P/S 2.03
P/FCF 33.42
P/OCF 17.19
P/B 2.22
P/tB 5.97
EV/EBITDA 13.02
EPS(TTM)4.47
EY3.74%
EPS(NY)4.83
Fwd EY4.04%
FCF(TTM)3.57
FCFY2.99%
OCF(TTM)6.95
OCFY5.82%
SpS58.73
BVpS53.8
TBVpS19.99
PEG (NY)3.33
PEG (5Y)2.09
Graham Number73.5565 (-38.42%)
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 7.88%
ROCE 7.32%
ROIC 5.8%
ROICexc 6.09%
ROICexgc 9.96%
OM 11.37%
PM (TTM) 7.22%
GM 22.45%
FCFM 6.09%
ROA(3y)3.51%
ROA(5y)4%
ROE(3y)6.18%
ROE(5y)6.66%
ROIC(3y)4.62%
ROIC(5y)4.24%
ROICexc(3y)4.82%
ROICexc(5y)4.43%
ROICexgc(3y)8.06%
ROICexgc(5y)7.51%
ROCE(3y)5.83%
ROCE(5y)5.36%
ROICexgc growth 3Y7.62%
ROICexgc growth 5Y-0.63%
ROICexc growth 3Y10.26%
ROICexc growth 5Y1.46%
OM growth 3Y16.52%
OM growth 5Y6.57%
PM growth 3Y-12.89%
PM growth 5Y5.71%
GM growth 3Y5.99%
GM growth 5Y2.61%
F-Score9
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.68
Debt/EBITDA 2.75
Cap/Depr 74.26%
Cap/Sales 5.74%
Interest Coverage 3.18
Cash Conversion 61.92%
Profit Quality 84.33%
Current Ratio 2.2
Quick Ratio 1.35
Altman-Z 2.71
F-Score9
WACC10.77%
ROIC/WACC0.54
Cap/Depr(3y)99.71%
Cap/Depr(5y)89.53%
Cap/Sales(3y)7.31%
Cap/Sales(5y)6.45%
Profit Quality(3y)151.62%
Profit Quality(5y)117.46%
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
EPS Next Y8.02%
EPS Next 2Y12.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.2%
Revenue growth 3Y8.74%
Revenue growth 5Y8.3%
Sales Q2Q%7.58%
Revenue Next Year4.19%
Revenue Next 2Y5.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y67.98%
EBIT growth 3Y26.7%
EBIT growth 5Y15.41%
EBIT Next Year75.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.8%
FCF growth 3Y69.09%
FCF growth 5Y-0.26%
OCF growth 1Y-32.05%
OCF growth 3Y25.08%
OCF growth 5Y5.59%

ARCOSA INC / ACA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 4 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


What is the profitability of ACA stock?

ARCOSA INC (ACA) has a profitability rating of 7 / 10.


What is the expected EPS growth for ARCOSA INC (ACA) stock?

The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 8.02% in the next year.


Can you provide the dividend sustainability for ACA stock?

The dividend rating of ARCOSA INC (ACA) is 5 / 10 and the dividend payout ratio is 4.81%.